...
首页> 外文期刊>Organic & biomolecular chemistry >Pyrazole-oxadiazole conjugates: synthesis, antiproliferative activity and inhibition of tubulin polymerization
【24h】

Pyrazole-oxadiazole conjugates: synthesis, antiproliferative activity and inhibition of tubulin polymerization

机译:吡唑-恶二唑结合物:合成,抗增殖活性和抑制微管蛋白聚合

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A number of pyrazole-oxadiazole conjugates were synthesized and evaluated for their ability to function as antiproliferative agents on various human cancer cell lines. These conjugates are comprised of pyrazole and oxadiazole scaffolds closely attached to each other without any spacer as two structural classes. The Type Ⅰ class has a trimethoxy substituent and the type Ⅱ class has a 3,4-(methylenedioxy) substituent on their A rings. Among these conjugates, 11a, 11d and 11f manifest potent cytotoxicity with IC_(50) values ranging from 1.5 μM to 11.2 μM and inhibit tubulin polymerization with IC_(50) values of 1.3 μM, 3.9 μM and 2.4 μM respectively. The cell cycle assay showed that treatment with these conjugates results in accumulation of cells in the G2/M phase and disrupts the microtubule network. Elucidation of zebrafish embryos revealed that the conjugates cause developmental defects. Molecular docking simulations determined the binding modes of these potent conjugates at the colchicine site of tubulin.
机译:合成了许多吡唑-恶二唑缀合物,并评估了它们在各种人类癌细胞系中作为抗增殖剂的能力。这些缀合物由彼此紧密连接的吡唑和恶二唑支架组成,没有任何间隔子作为两个结构类别。 Ⅰ类具有一个三甲氧基取代基,而Ⅱ类具有在它们的A环上的3,4-(亚甲二氧基)取代基。在这些缀合物中,11a,11d和11f表现出强的细胞毒性,IC_(50)值为1.5μM至11.2μM,并抑制微管蛋白聚合,IC_(50)的值分别为1.3μM,3.9μM和2.4μM。细胞周期分析表明,用这些缀合物处理会导致细胞在G2 / M期积累,并破坏微管网络。斑马鱼胚胎的阐明表明,缀合物导致发育缺陷。分子对接模拟确定了这些有效结合物在微管蛋白秋水仙碱位点的结合模式。

著录项

  • 来源
    《Organic & biomolecular chemistry》 |2014年第40期|7993-8007|共15页
  • 作者单位

    Medicinal Chemistry and Pharmacology, CSIR-Indian Institute of Chemical Technology, Hyderabad 500 007, India,Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad 500 037, India;

    Medicinal Chemistry and Pharmacology, CSIR-Indian Institute of Chemical Technology, Hyderabad 500 007, India;

    Centre for Chemical Biology CSIR-Indian Institute of Chemical Technology, Hyderabad 500 007, India;

    Medicinal Chemistry and Pharmacology, CSIR-Indian Institute of Chemical Technology, Hyderabad 500 007, India;

    Medicinal Chemistry and Pharmacology, CSIR-Indian Institute of Chemical Technology, Hyderabad 500 007, India;

    Medicinal Chemistry and Pharmacology, CSIR-Indian Institute of Chemical Technology, Hyderabad 500 007, India;

    Nuclear Magnetic Resonance Centre, CSIR-Indian Institute of Chemical Technology, Hyderabad 500 007, India;

    CSIR - Centre for Cellular and Molecular Biology, Hyderabad 500 007, India;

    CSIR - Centre for Cellular and Molecular Biology, Hyderabad 500 007, India;

    Centre for Chemical Biology CSIR-Indian Institute of Chemical Technology, Hyderabad 500 007, India;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号